LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Historical Holders from Q1 2024 to Q3 2025

Symbol
LENZ on Nasdaq
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
28,248,974
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
29,140,610
Holdings value
$1,355,578,952
% of all portfolios
0.01%
Number of holders
166
Number of buys
121
Number of sells
-26
Average buys %
+0.01%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $199,280,597 4,278,243 FMR LLC 31 Oct 2025
RA CAPITAL MANAGEMENT, L.P. 13.6% -10% $198,668,637 +$209,610 4,265,106 +0.11% RA Capital Management, L.P. 05 Nov 2025
BlackRock, Inc. 5.1% $67,208,749 1,442,864 BlackRock, Inc. 30 Sep 2025
Point72 Asset Management, L.P. 4.8% $63,244,042 1,357,751 Steven A. Cohen 30 Sep 2025
Paradigm Biocapital Advisors LP 3.8% -28% $50,001,813 -$16,133,961 1,073,461 -24% Paradigm BioCapital Advisors LP 30 Sep 2025
Versant Venture Capital VI, L.P. 3.4% -18% $48,936,901 -$6,192,532 1,050,599 -11% Versant Venture Capital VI, L.P. 05 Nov 2025

Institutional Holders of LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 29,140,610 $1,355,578,952 +$224,910,234 $46.58 166
2025 Q2 24,727,156 $725,109,733 +$107,969,187 $29.31 113
2025 Q1 21,072,237 $541,761,121 +$29,092,976 $25.71 105
2024 Q4 19,863,850 $573,239,116 +$35,341,897 $28.87 94
2024 Q3 18,735,645 $444,795,067 -$1,423,016 $23.74 78
2024 Q2 18,913,542 $327,016,869 +$45,118,057 $17.29 63
2024 Q1 16,171,755 $361,085,230 +$360,723,016 $22.33 54